Immune checkpoint inhibitors-related hyperprogressive disease : a case report
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Zhonghua zhong liu za zhi [Chinese journal of oncology - 43(2021), 9 vom: 23. Sept., Seite 979-980 |
| Sprache: |
Chinesisch |
|---|
| Beteiligte Personen: |
Zhang, J Y [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bladder neoplasms |
|---|
| Anmerkungen: |
Date Completed 20.10.2021 Date Revised 20.10.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3760/cma.j.cn112152-20200502-00403 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330725572 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330725572 | ||
| 003 | DE-627 | ||
| 005 | 20231225211912.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||chi c | ||
| 024 | 7 | |a 10.3760/cma.j.cn112152-20200502-00403 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1102.xml |
| 035 | |a (DE-627)NLM330725572 | ||
| 035 | |a (NLM)34530583 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 100 | 1 | |a Zhang, J Y |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immune checkpoint inhibitors-related hyperprogressive disease |b a case report |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.10.2021 | ||
| 500 | |a Date Revised 20.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bladder neoplasms | |
| 650 | 4 | |a Hyperprogressive disease | |
| 650 | 4 | |a Immune checkpoint inhibitors | |
| 650 | 4 | |a Tumor growth rate | |
| 650 | 7 | |a Immune Checkpoint Inhibitors |2 NLM | |
| 700 | 1 | |a Peng, Y M |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, K X |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, W |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, X |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, C Y |e verfasserin |4 aut | |
| 700 | 1 | |a Cui, H J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zhonghua zhong liu za zhi [Chinese journal of oncology |d 1989 |g 43(2021), 9 vom: 23. Sept., Seite 979-980 |w (DE-627)NLM000961434 |x 0253-3766 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2021 |g number:9 |g day:23 |g month:09 |g pages:979-980 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.cn112152-20200502-00403 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2021 |e 9 |b 23 |c 09 |h 979-980 | ||